Review of checkpoint immunotherapy for the management of non-small cell lung cancer

Review of checkpoint immunotherapy for the management of non-small cell lung cancer

Shine Raju,1 Ranjit Joseph,2 Sameep Sehgal3 1Division of Geriatrics and Palliative Care, Case Western University, Cleveland, OH, USA; 2Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC, USA; 3Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine,...

Full description

Bibliographic Details
Main Authors: Raju S, Joseph R, Sehgal S
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:ImmunoTargets and Therapy
Subjects:
Non-small cell lung cancer
PD-1 inhibitors
PD-L1 inhibitors
Pembrolizumab
Nivolumab 6. Atezolizumab
Online Access:https://www.dovepress.com/review-of-checkpoint-immunotherapy-for-the-management-of-non-small-cel-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/review-of-checkpoint-immunotherapy-for-the-management-of-non-small-cel-peer-reviewed-article-ITT

Similar Items